J. Goldman & Co’s Core Scientific CORZ Stock Holding History

J. Goldman & Co’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-171,363	Closed	-$4.03M	–	740
2026 Q1	$2.56M	Buy	+171,363	New	+$2.92M	0.07%	281
2025 Q3	–	Sell	-57,093	Closed	-$975K	–	481
2025 Q2	$975K	Sell	57,093 -1,218,419	-96%	-$12.2M	0.02%	339
2025 Q1	$9.23M	Buy	+1,275,512	New	+$14.5M	0.23%	135

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

J. Goldman & Co's CORZ Position: Q2 2026 in Review

J. Goldman & Co sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 171,363 shares — an estimated $4.03M sold.

J. Goldman & Co first reported a position in CORZ in Q1 2025 and held it in 3 quarters. The position peaked at $9.23M in Q1 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

J. Goldman & Co reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
J. Goldman & Co sold 171,363 Core Scientific shares in Q2 2026, an estimated $4.03M.
J. Goldman & Co first reported a position in Core Scientific in Q1 2025 and held it in 3 quarters.
J. Goldman & Co's Core Scientific position peaked at $9.23M in Q1 2025.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.